FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Marketing

Issues Found in TV Ad Major Statements: Study

FDA advertising researchers say that drug companies still are not following recommendations from previous studies to improve communication of major st...

Human Drugs

FDA Approves 1st Digital Tracking Medicine

FDA approves an Otsuka Pharmaceutical NDA for mental disorder-treating Abilify MyCite (aripiprazole tablets with sensor) the first drug-device combin...

Medical Devices

Safety Alert on Silicone Marketed as Body Contouring Product

FDA issues a safety alert about illegal use of injectable silicone for body contouring and associated injuries and disfigurement that can result from ...

Federal Register

Class 2 for Indirect Immunofluorescence Microscope

Federal Register notice: FDA classifies the automated indirect immunofluorescence microscope and software-assisted system into Class 2 (special contro...

Medical Devices

Companies Making Cybersecurity Progress: Schwartz

CDRH associate director Suzanne Schwartz praises the progress medical device manufacturers have made in addressing cybersecurity issues.

Human Drugs

No FDA-Approved Products with Kratom: Gottlieb

FDA commissioner Scott Gottlieb cautions that the agency has not approved any products containing kratom and is taking action against dietary suppleme...

Human Drugs

Ways to Improve FDA Unapproved Drugs Initiative

Researchers suggest ways to improve generic competition for previously unapproved drugs that have gained FDA approval under the agencys Unapproved Dru...

Multiple Violations Found at RTI Surgical

FDA warns RTI Surgical about multiple violations in its continuing manufacture of a bone graft product that is regulated as a drug and biologic.

Federal Register

Prostatic Artery Embolization Device into Class 2

Federal Register notice: FDA classifies the prostatic artery embolization device into Class 2 (special controls).

FDA General

Latest FDA Warning Letters

FDA releases its latest batch of Warning Letters that includes Lupin Ltd., ProSun International and RTI Surgical.